Doenças Cardiovasculares/genética; Regulação da Expressão Gênica; Inflamação/genética; MicroRNAs/genética; MicroRNAs/metabolismo; Neoplasias/genética; Animais; Linfócitos B/fisiologia; Diferenciação Celular/genética; Síndrome de Down/genética; Feminino; Humanos; Macrófagos/fisiologia; Família Multigênica; NF-kappa B/genética; NF-kappa B/metabolismo; Linfócitos T/fisiologia; Fator de Transcrição AP-1/metabolismo

3T3-L1; 3'-UTR; 3'-untranslated region; AICDA; AML; AP-1; AT(1)R; Ang II; B-CLL; B-cell Integration Cluster; B-cell chronic lymphocytic leukemia; BACH1; BIC; BMDM; BRCA1; BT-549; Burkitt's lymphoma cell line; C/EBPß; CCAAT/enhancer-binding protein ß; CCR4-NOT; CFH; CREB; Cancer; Cardiovascular disease; ChIP; CpG; Cytosine (phosphodiester bond) Guanine; DG75; DGCR8; DLBCL; DS; Dcp1/2; Down syndrome; Drosha and the DiGeorge critical region 8 protein; E26 transformation-specific; EBNA2; EBV; EBV nuclear antigen 2; ERBB2; ETS1; Epstein­Barr virus; Ets; FADD; FBJ murine osteosarcoma viral oncogene homolog B; FOXP3; Fas (TNRFSF6)-associated via death domain; FosB; Gene regulation; H2A; H3; H3K4; H3K9; HDACs; HL-60; HOXA9; HSPCs; Hematopoiesis; Hsa21; IFN-ß/γ; IKBKE; IL-10; IL17RB; INF-α/ß; INPP5D; IRAK3; IRF3; IRFE; ISRE; Immunity; IκBα; JARID2; JNK; JY; Jumonji, AT rich interactive domain 2; JunB; K562; KH-type splicing regulatory protein; KHSRP; KSHV; Kaposi's sarcoma-associated herpesvirus; LMP1; LPS; MC3; MDV; MEIS1; MIR155HG; MYB; MYD88; Marek's disease virus; MeCP2; Myeloid differentiation primary response gene 88; NF-κB; NF-κB inhibitor, alpha; NOD; ORF; PBX; PCCD4; PDCs; PEL; PKC; PMBL; Poly(I:C); Pre-miRNAs; R1699Q; RIG-I; RIPK1; Receptor (TNFRSF)-interacting serine­threonine kinase 1; SATB1; SKP2; SMAD; SNP; SNP in a miRNA target site; SOCS; SOCS1; SPI1; STAT3; TAB2; TCF12; TGF-ß; TGF-ß activated kinase 1/MAP3K7 binding protein 2; THP-1; TLR; TNF-α; Toll-like receptor; Tregs; Trisomy 21; Ts21; VM; VSV; ZNF652; a family of small nonprotein-coding RNAs; activation-induced cytidine deaminase; activator protein 1; acute myeloid leukemia; an EBV-immortalized B-cell lymphoblastoid cell line; angiotensin II; angiotensin II type 1 receptor; arginine to glutamine amino acid change at position 1699 in the BRCA1 gene; basic leucine zipper transcription factor 1; bone marrow-derived macrophages; breast cancer 1, early onset; c-Jun N-terminal kinase; cAMP response element-binding; carbon catabolite repressor protein 4-General negative regulator of transcription; ceRNAs; cell line derived from 3T3 cells; chromatin immunoprecipitation; competing endogenous RNAs; complement factor H; complementary "star form" of miRNA strand; decapping enzyme homologs A, B, and 2; diffuse large B-cell lymphoma; forkhead box P3; hPBMC; hematopoietic stem­progenitor cells; histone H2A; histone H3; histone deacetylase complexes; homeobox protein; human acute monocytic leukemia cell line; human breast carcinoma cell line; human chromosome 21; human peripheral blood mononuclear cells; human promyelocytic leukemia cell line; immortalized myelogenous erythroleukemia cell line; inhibitor of NF-κB subunit epsilon; inositol polyphosphate-5-phosphatase, 145kDa (a.k.a. SHIP1); interferon beta/gamma; interferon regulatory factor 3; interferon regulatory factor element; interferon-alpha/beta; interferon-sensitive response element; interleukin-1 receptor-associated kinase 3; interleukin-10; interleukin-17 receptor B; latent membrane protein 1; lipopolysaccharide; lysine 4 of histone H3; lysine 9 of histone 3; methyl-CpG-binding protein; miR-155 host gene; miR-155*; miR-155-3p; miRISC; miRNA*; miRNA-induced silencing complex; miRNAs; miRSNP; mothers against decapentaplegic homolog; ncRNAs; non-coding RNAs; nuclear factor κB; nucleotide-binding oligomerization domain-containing protein; open reading frame; p53; plasmacytoid dendritic cells; polyriboinosinic: polyribocytidylic acid; pre-B-cell leukemia transcription factor; premature miRNAs; pri-miRNAs; primary effusion lymphoma; primary mediastinal B-cell lymphoma; primary transcripts of miRNAs; programmed cell death protein 4; protein kinase C; regulatory T-cells; retinoic acid-inducible gene I; s-phase kinase-associated protein 2; signal transducer and activator of transcription 3; single nucleotide polymorphism; special AT-rich binding protein-1; spleen focus forming virus (SFFV) proviral integration oncogene (a.k.a. PU.1); suppressor of cytokine signaling 1; transcription factor 12; transcription factor Jun-B; transforming growth factor beta; tumor necrosis factor-alpha; tumor protein 53; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2; v-ets erythroblastosis virus E26 oncogene homolog 1 (avian); v-myb myeloblastosis viral oncogene homolog; vesicular stomatitis virus; viral myocarditis; zinc finger protein 652